Literature DB >> 16564601

An epidemiologic study of early onset lung cancer.

Carol J Etzel1, Mei Lu, Kelly Merriman, Mei Liu, Ara Vaporciyan, Margaret R Spitz.   

Abstract

Using cases from an ongoing case-control study, we completed a case series analysis by comparing epidemiologic, clinical and survival characteristics among lung cancer patients characterized by age at diagnosis. Our sample included 230 early onset lung cancer (EOLC) (all Caucasian and no older than 50 years of age at diagnosis) and 426 later-onset cases (LOLC) (all Caucasian and no younger than 70 years of age at diagnosis) who were referred to The University of Texas M.D. Anderson Cancer Center, Houston between 1995 and 2004. Detailed lifestyle, exposure, clinical, survival and self-reported cancer family history data were available from personal interviews. We observed a higher proportion of never smokers (23.9%) for the EOLC cases as compared to the LOLC cases (17.6%) and a higher proportion of former smokers (59.4%) among the LOLC cases compared to EOLC cases (17.8%). Adenocarcinoma was the most common histology (55.2%) among the EOLC cases. More (83.4%) of the EOLC cases presented with stage 3 or 4 lung cancer compared to the LOLC cases (58.6%). Median (M) survival was 16.7 months among the EOLC cases (M = 19.2 months for the LOLC cases) and the 24-month survival rate was 20.6% for the EOLC cases and 29.5% for the LOLC cases. Female EOLC cases (M = 20.7 months) exhibited better survival than male EOLC cases (M = 13.0 months, P = 0.004). EOLC cases diagnosed with squamous cell carcinoma had poorer survival (M = 8.2 months) compared to cases with other histologies (P < 0.001). For both groups, higher stage at presentation was associated with poorer survival (P < 0.001). These findings support the need for further study in the characterization and identification of genetic factors that influence and modulate early onset lung cancer risk and outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16564601     DOI: 10.1016/j.lungcan.2005.11.018

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

Review 1.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

2.  Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Michele L Coté; Mei Liu; Stefano Bonassi; Monica Neri; Ann G Schwartz; David C Christiani; Margaret R Spitz; Joshua E Muscat; Gad Rennert; Katja K Aben; Angeline S Andrew; Vladimir Bencko; Heike Bickeböller; Paolo Boffetta; Paul Brennan; Hermann Brenner; Eric J Duell; Eleonora Fabianova; John K Field; Lenka Foretova; Søren Friis; Curtis C Harris; Ivana Holcatova; Yun-Chul Hong; Dolores Isla; Vladimir Janout; Lambertus A Kiemeney; Chikako Kiyohara; Qing Lan; Philip Lazarus; Jolanta Lissowska; Loic Le Marchand; Dana Mates; Keitaro Matsuo; Jose I Mayordomo; John R McLaughlin; Hal Morgenstern; Heiko Müeller; Irene Orlow; Bernard J Park; Mila Pinchev; Olaide Y Raji; Hedy S Rennert; Peter Rudnai; Adeline Seow; Isabelle Stucker; Neonila Szeszenia-Dabrowska; M Dawn Teare; Anne Tjønnelan; Donatella Ugolini; Henricus F M van der Heijden; Erich Wichmann; John K Wiencke; Penella J Woll; Ping Yang; David Zaridze; Zuo-Feng Zhang; Carol J Etzel; Rayjean J Hung
Journal:  Eur J Cancer       Date:  2012-03-19       Impact factor: 9.162

Review 3.  Lung cancer in never smokers: molecular profiles and therapeutic implications.

Authors:  Charles M Rudin; Erika Avila-Tang; Curtis C Harris; James G Herman; Fred R Hirsch; William Pao; Ann G Schwartz; Kirsi H Vahakangas; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

4.  Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.

Authors:  Maria N Timofeeva; Rayjean J Hung; Thorunn Rafnar; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; James D McKay; Yufei Wang; Juncheng Dai; Valerie Gaborieau; John McLaughlin; Darren Brenner; Steven A Narod; Neil E Caporaso; Demetrius Albanes; Michael Thun; Timothy Eisen; H-Erich Wichmann; Albert Rosenberger; Younghun Han; Wei Chen; Dakai Zhu; Margaret Spitz; Xifeng Wu; Mala Pande; Yang Zhao; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Maiken Elvestad Gabrielsen; Frank Skorpen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Simone Benhamou; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Thomas Muley; Hendrik Dienemann; Gudmar Thorleifsson; Hongbing Shen; Kari Stefansson; Paul Brennan; Christopher I Amos; Richard Houlston; Maria Teresa Landi
Journal:  Hum Mol Genet       Date:  2012-08-16       Impact factor: 6.150

5.  Lung cancer incidence and survival in chromium exposed individuals with respect to expression of anti-apoptotic protein survivin and tumor suppressor P53 protein.

Authors:  Erika Halasova; M Adamkov; T Matakova; E Kavcova; I Poliacek; A Singliar
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

6.  Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium.

Authors:  Ruyi Huang; Yongyue Wei; Rayjean J Hung; Geoffrey Liu; Li Su; Ruyang Zhang; Xuchen Zong; Zuo-Feng Zhang; Hal Morgenstern; Irene Brüske; Joachim Heinrich; Yun-Chul Hong; Jin Hee Kim; Michele Cote; Angela Wenzlaff; Ann G Schwartz; Isabelle Stucker; John Mclaughlin; Michael W Marcus; Michael P A Davies; Triantafillos Liloglou; John K Field; Keitaro Matsuo; Matt Barnett; Mark Thornquist; Gary Goodman; Yi Wang; Size Chen; Ping Yang; Eric J Duell; Angeline S Andrew; Philip Lazarus; Joshua Muscat; Penella Woll; Janet Horsman; M Dawn Teare; Anath Flugelman; Gad Rennert; Yan Zhang; Hermann Brenner; Christa Stegmaier; Erik H F M van der Heijden; Katja Aben; Lambertus Kiemeney; Juan Barros-Dios; Monica Pérez-Ríos; Alberto Ruano-Ravina; Neil E Caporaso; Pier Alberto Bertazzi; Maria Teresa Landi; Juncheng Dai; Hongbing Hongbing Shen; Guillermo Fernandez-Tardon; Marta Rodriguez-Suarez; Adonina Tardon; David C Christiani
Journal:  EBioMedicine       Date:  2015-11       Impact factor: 8.143

7.  Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study.

Authors:  Kun Wang; Likwang Chen; Chi-Kuei Hsu; Chih-Cheng Lai
Journal:  PeerJ       Date:  2016-12-20       Impact factor: 2.984

Review 8.  [Advances of ectopic ACTH syndrome complicated by lung cancer].

Authors:  Liang Yang; Zhenyu Deng; Linhai Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-01

9.  Expression of cytochrome P450 2A13 in human non-small cell lung cancer and its clinical significance.

Authors:  Li Sun; Xiaoli Fan
Journal:  J Biomed Res       Date:  2013-03-24

10.  Younger patients operated for lung cancer have a better prognosis.

Authors:  Tomasz Marjanski; Robert Dziedzic; Danush Davoodi; Sofie Josefsson; Wioletta Sawicka; Witold Rzyman
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.